miDiagnostics key facts
- Developer of chip-based technology designed to bring miniaturized lab-quality tests with built-in connectivity.
- miDiagnostics’s last known valuation is $294.6M.
- It has raised $216.7M; the latest was Later Stage VC ($23.0M) in Dec 2024.
- Notable investors include Participatiemaatschappij Vlaanderen, Alychlo, VMF Invest, Imec, Johns Hopkins Technology Ventures — 14 tracked in total.
- Status: Privately Held (backing).
Who backs miDiagnostics
14+- ·The complete investor list: 14 names
- ·Watch miDiagnostics: the Monday email on marks, rounds and moves
miDiagnostics funding rounds
No funding rounds for miDiagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
miDiagnostics valuation
miDiagnostics's last known valuation is $295 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
miDiagnostics investors
14 investors are on record for miDiagnostics, including Participatiemaatschappij Vlaanderen, Alychlo, VMF Invest and Imec.
About miDiagnostics
Developer of chip-based technology designed to bring miniaturized lab-quality tests with built-in connectivity. The company's technology combines a nanofluidic processor on a chip and a compact reader to measure virtually any biomarker from easy-to-access samples such as finger-prick blood or nasal swabs, enabling patients and clinicians to provide rapid diagnostics anywhere and at any time.
- Sector
- Healthcare
- HQ
- Leuven, Belgium
- Founded
- 2015
- Employees
- 70
- Website
- midiagnostics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
miDiagnostics’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.